Condition
T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma clinical trials that are recruiting, at sites in 3 countries (most in China (1), Hong Kong (1), Italy (1)). By phase: Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
New treatment approach for children newly diagnosed with T‑cell acute lymphoblastic leukemia using dasatinib, venetoclax, and homoharringtonine
This study will try adding dasatinib, venetoclax, and homoharringtonine to standard chemotherapy for children and adolescents newly diagnosed with T‑cell acute lymphoblastic leukemia to see if it increases deep (MRD‑negative) remissions and lowers relapse.
-
CD7-CAR-T cell therapy for children with relapsed or refractory T-cell leukemia
This study is testing a new CAR-T cell therapy for children with hard-to-treat T-cell leukemia to see if it can help them when other treatments have not worked.
Related topics
Quick answers
How many T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (1 trial), Hong Kong (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.